Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Dyne Therapeutics, Inc. market cap for the quarter ending 2026-07-24 was $4.56B, a 221.84% increase year-over-year.
Dyne Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $3.68B, a 238.01% increase year-over-year.
Dyne Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $3B, a 152.05% increase year-over-year.
Dyne Therapeutics, Inc. market cap for the quarter ending 2025-12-31 was $3.22B, a 33.77% increase year-over-year.
Dyne Therapeutics, Inc. market cap for fiscal 2026 was $4.56B.
Dyne Therapeutics, Inc. market cap for fiscal 2025 was $3.22B, a 33.77% increase from fiscal 2024.
Dyne Therapeutics, Inc. market cap for fiscal 2024 was $2.41B, a 194.87% increase from fiscal 2023.
Dyne Therapeutics, Inc. market cap for fiscal 2023 was $817.53M, a 26.78% increase from fiscal 2022.